Porcine Vaccine Industrial and Market studies - North America Industry Analysis, Size, Share, Growth, Trends, and Forecast Pharmaceutical 2016 - 2024
"Porcine
Vaccine Market - North America Industry Analysis, Size, Share,
Growth, Trends, and Forecast 2016 - 2024"
The Report covers current Market Trends, Worldwide Analysis, Global
Forecast, Review, Share, Size, Growth, Effect.
Description-
North
America Porcine Vaccine Market: Scope of the Report
This report on the porcine vaccine market analyzes
the current and future scenario of the North America market. Increase
in disease indication among swine, technological advancement of RNA
strand methodology, and cultivation of pig for growth in standard of
living is accounted to form growth in porcine vaccine segment.
Increase trading facilities of live hogs/pigs, demand of pork meat
and innovation through clinical research activities are some of the
drivers expected to drive the North America porcine vaccine market
during the forecast period.
The
North America porcine vaccine market report comprises an elaborate
executive summary, which includes market snapshot that provides
information about various segments. It also provides information and
data analysis of the country’s market with respect to the segments
based on disease indication, technology, end-user, and country. A
detailed qualitative analysis of drivers and restraints, and
opportunities has been provided in the market overview section.
Additionally, the section comprises Porters Five Forces Analysis to
help understand the competitive landscape in the market. This section
also provides market attractiveness analysis in terms of country and
market share analysis by key players, thus presenting a thorough
analysis of the overall competitive scenario in the North America
porcine vaccine market.
North America Porcine Vaccine Market:
Segmentation
Based on disease indication, the market has been
segmented into diarrhoea, swine influenza, porcine reproductive and
respiratory virus (PRRSV), porcine circovirus associated disease
(PCVAD) and others. Diarrhoea is the most widely spread disease
across the North America; porcine epidemic diarrhea virus (PEDV) hit
the United States in 2013 and spread to Canada in 2014 which infected
piglets and has 80%-100% mortality rate. The market segments have
been analyzed based on available approved products,
cost-effectiveness, and preference from veterans for treating the
swine with various disease indications. The market size and forecast
for each of these segments have been provided for the period from
2014 to 2024, along with their respective CAGRs for the forecast
period from 2016 to 2024, considering 2015 as the base year.
Based on technology, the North America porcine
vaccine market has been segmented into inactivated vaccines, live
attenuated vaccines, toxoid vaccines, recombinant vaccines, conjugate
vaccines, and DNA vaccines. The market segments have been extensively
analyzed based on increase in demand for disease treatment such as
PEDv, PRRSv, and PCVAD. Demand of disease free pork meat, and
increasing awareness for treating the cultivated pigs are driving the
market share of technological segment. Different types of end-user
utilize porcine vaccines to treat swine diseases either. Under the
end-user segment, hog/pig production farms plays a major role
followed by veterinary hospitals. The market size and forecast in
terms of US$ Mn for each segment have been provided for the period
from 2014 to 2024. The report also provides the compound annual
growth rate (CAGR %) for each market segment for the forecast period
from 2016 to 2024, considering 2015 as the base year.
North America Porcine Vaccine Market:
Geographical and Competitive Dynamics
Geographically, the North America porcine vaccine
market has been categorized into key countries: North America (the
U.S. and Canada). The market size and forecast for each of these
regions and the mentioned countries have been provided for the period
from 2014 to 2024, along with their respective CAGRs for the forecast
period from 2016 to 2024, considering 2015 as the base year.
The report also profiles major players in the
North America porcine vaccine market based on various attributes such
as company overview, financial overview, product portfolio, business
strategies, SWOT analysis, and recent developments. Major players
profiled in this report include Bayer AG., Bimeda Animal Health,
Boehringer Ingelheim GmbH, Ceva Santé Animale, Elanco (Eli Lilly and
Company), Merck & Co., Inc., Merial (Sanofi), Vetoquinol, Zoetis
Inc. and others.
The North America porcine vaccine market has been
segmented as follows:
North America Porcine Vaccine Market, by
Disease Indication
- Diarrhoea
- Swine Influenza
- Arthritis
- Bordatella Rhinitis
- Porcine Reproductive and Respiratory Virus (PRRSV)
- Porcine Circovirus Associated Disease (PCVAD)
- Others
North America Porcine Vaccine Market, by
Technology
- Inactivated Vaccines
- Live Attenuated Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- Conjugate Vaccines
- DNA Vaccines
North America Porcine Vaccine Market, by
End-user
- Veterinary Hospitals
- Hog/Pig Production Farm
North America Porcine Vaccine Market, by
Country
- North America
- U.S.
- Canada
Comments
Post a Comment